Thinking Globally: BCRF's Reach in 2008
"In 2001, when we started funding an Israeli extension of the New York Breast Cancer Study's assessment of hereditary risk, we knew we were not only supporting quality science, but beginning a global approach to a global problem. That in just six years we have expanded our research funding to 28 countries on six continents is a testament to the vigor of that vision."
Larry Norton, MD, Chairman, BCRF Executive Board of Scientific Advisors; Deputy Physician-in-Chief, Director of Breast Cancer Programs, Memorial Sloan-Kettering Cancer Center, New York City.
The Breast Cancer Research Foundation (BCRF) has supported international research-at a rapidly increasing pace-for the past seven years. And that's a good thing, since public health indicators suggest that by 2020, 70 percent of all breast cancer cases will be in developing countries. This year, BCRF funds a greater number of international projects than ever before. Some are collaborations between U.S.-based researchers working with significant populations of women with breast cancer and their doctors in other countries. Other projects are initiated locally and range from cutting-edge laboratory research about the molecular basis of breast cancer, to establishing and improving basic standards of care, all so that women with breast cancer throughout the world have better outcomes.
|
